drugset / Trial / NCT04735926

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency

NCT04735926

Phase 2/3 Completed 674 enrolled Faes Farma, S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomised, double-blind, double-dummy, multicentre, dose-ranging clinical trial in subjects with vitamin D deficiency or insufficiency. Its general objective is to determine the efficacy and safety of different doses of calcifediol soft gelatin capsules (SGCs) compared to placebo.

Timeline

Start
2020-12-23
Primary completion
2022-07-21
Completion
2023-04-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcifediol Unknown 75 ug Oral
Subject Calcifediol Unknown 100 ug Oral
Subject Calcifediol Unknown 125 ug Oral

Indications